Rank | Gene Set | Z-score |
---|---|---|
1 | low-density lipoprotein particle clearance (GO:0034383) | 5.79112786 |
2 | behavioral response to nicotine (GO:0035095) | 5.33119761 |
3 | tooth mineralization (GO:0034505) | 5.12651999 |
4 | protein heterotrimerization (GO:0070208) | 4.80775638 |
5 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.29674547 |
6 | regulation of sequestering of triglyceride (GO:0010889) | 4.22419229 |
7 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.09706789 |
8 | triglyceride catabolic process (GO:0019433) | 4.00108378 |
9 | valine metabolic process (GO:0006573) | 3.93731205 |
10 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.90909932 |
11 | white fat cell differentiation (GO:0050872) | 3.88423642 |
12 | positive regulation of fatty acid oxidation (GO:0046321) | 3.87088822 |
13 | regulation of glomerulus development (GO:0090192) | 3.82286421 |
14 | angiogenesis involved in wound healing (GO:0060055) | 3.80134767 |
15 | negative regulation of response to food (GO:0032096) | 3.76213856 |
16 | negative regulation of appetite (GO:0032099) | 3.76213856 |
17 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.76064186 |
18 | collagen fibril organization (GO:0030199) | 3.75985776 |
19 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.75105210 |
20 | response to gravity (GO:0009629) | 3.68559379 |
21 | fatty acid transmembrane transport (GO:1902001) | 3.67394558 |
22 | acylglycerol catabolic process (GO:0046464) | 3.65136870 |
23 | neutral lipid catabolic process (GO:0046461) | 3.65136870 |
24 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.63285221 |
25 | cellular response to vitamin (GO:0071295) | 3.62051722 |
26 | lipid particle organization (GO:0034389) | 3.61544486 |
27 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.59913734 |
28 | brown fat cell differentiation (GO:0050873) | 3.57149616 |
29 | fatty acid beta-oxidation (GO:0006635) | 3.55964427 |
30 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.50074891 |
31 | positive regulation of glomerulus development (GO:0090193) | 3.49734116 |
32 | pharyngeal system development (GO:0060037) | 3.48432093 |
33 | middle ear morphogenesis (GO:0042474) | 3.47939750 |
34 | kidney mesenchyme development (GO:0072074) | 3.47335034 |
35 | positive regulation of metanephros development (GO:0072216) | 3.46932513 |
36 | endothelial cell morphogenesis (GO:0001886) | 3.44738068 |
37 | biotin metabolic process (GO:0006768) | 3.40348404 |
38 | carnitine shuttle (GO:0006853) | 3.37530527 |
39 | apoptotic cell clearance (GO:0043277) | 3.35606777 |
40 | lymphangiogenesis (GO:0001946) | 3.34211207 |
41 | plasma membrane repair (GO:0001778) | 3.32833912 |
42 | basement membrane organization (GO:0071711) | 3.32374015 |
43 | regulation of fatty acid oxidation (GO:0046320) | 3.29940776 |
44 | regulation of cholesterol storage (GO:0010885) | 3.25645136 |
45 | negative regulation of fatty acid transport (GO:2000192) | 3.24182396 |
46 | chondrocyte proliferation (GO:0035988) | 3.23343706 |
47 | sulfation (GO:0051923) | 3.21981121 |
48 | cellular response to ATP (GO:0071318) | 3.21234622 |
49 | fatty acid oxidation (GO:0019395) | 3.19491240 |
50 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.18444464 |
51 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.18111731 |
52 | regulation of tight junction assembly (GO:2000810) | 3.17250817 |
53 | cell adhesion mediated by integrin (GO:0033627) | 3.16677037 |
54 | epithelial cell-cell adhesion (GO:0090136) | 3.16199432 |
55 | metanephric mesenchyme development (GO:0072075) | 3.16130353 |
56 | cell migration involved in heart development (GO:0060973) | 3.14261781 |
57 | lipid oxidation (GO:0034440) | 3.12667163 |
58 | lung morphogenesis (GO:0060425) | 3.12346512 |
59 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.10445374 |
60 | skin morphogenesis (GO:0043589) | 3.08156233 |
61 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.07758027 |
62 | epoxygenase P450 pathway (GO:0019373) | 3.06257028 |
63 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.05030599 |
64 | renal filtration (GO:0097205) | 3.04908845 |
65 | stress fiber assembly (GO:0043149) | 3.04100738 |
66 | carnitine transport (GO:0015879) | 3.02901091 |
67 | amino-acid betaine transport (GO:0015838) | 3.02901091 |
68 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.02728298 |
69 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.01273079 |
70 | cell proliferation in forebrain (GO:0021846) | 3.00333594 |
71 | fatty acid catabolic process (GO:0009062) | 2.97566340 |
72 | lysine metabolic process (GO:0006553) | 2.97557790 |
73 | lysine catabolic process (GO:0006554) | 2.97557790 |
74 | tricarboxylic acid metabolic process (GO:0072350) | 2.96089108 |
75 | triglyceride biosynthetic process (GO:0019432) | 2.94187624 |
76 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.93558283 |
77 | gamma-aminobutyric acid transport (GO:0015812) | 2.93117623 |
78 | serotonin metabolic process (GO:0042428) | 2.92585337 |
79 | cell-substrate junction assembly (GO:0007044) | 2.91551216 |
80 | aorta morphogenesis (GO:0035909) | 2.91425873 |
81 | ovulation from ovarian follicle (GO:0001542) | 2.88459277 |
82 | base-excision repair, AP site formation (GO:0006285) | 2.87768080 |
83 | branched-chain amino acid metabolic process (GO:0009081) | 2.85242860 |
84 | glomerular filtration (GO:0003094) | 2.84954230 |
85 | carnitine transmembrane transport (GO:1902603) | 2.84850536 |
86 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.84398543 |
87 | acylglycerol biosynthetic process (GO:0046463) | 2.83644675 |
88 | neutral lipid biosynthetic process (GO:0046460) | 2.83644675 |
89 | endodermal cell differentiation (GO:0035987) | 2.83537008 |
90 | quaternary ammonium group transport (GO:0015697) | 2.82773389 |
91 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.82378817 |
92 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.82378817 |
93 | primary amino compound metabolic process (GO:1901160) | 2.81817311 |
94 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.78969334 |
95 | 2-oxoglutarate metabolic process (GO:0006103) | 2.77616907 |
96 | metanephric nephron tubule development (GO:0072234) | 2.77283019 |
97 | metanephric tubule development (GO:0072170) | 2.77283019 |
98 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.77241826 |
99 | growth hormone receptor signaling pathway (GO:0060396) | 2.76457240 |
100 | alpha-linolenic acid metabolic process (GO:0036109) | 2.75975643 |
101 | negative regulation of membrane potential (GO:0045837) | 2.75904342 |
102 | oxaloacetate metabolic process (GO:0006107) | 2.74630691 |
103 | metanephric nephron epithelium development (GO:0072243) | 2.74274726 |
104 | acetyl-CoA metabolic process (GO:0006084) | 2.73971775 |
105 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.71661245 |
106 | regulation of endothelial cell differentiation (GO:0045601) | 2.70416630 |
107 | axon extension involved in axon guidance (GO:0048846) | 2.69622083 |
108 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.69622083 |
109 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.67877946 |
110 | outer ear morphogenesis (GO:0042473) | 2.67250437 |
111 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.66350687 |
112 | positive regulation of glucose import (GO:0046326) | 2.65693068 |
113 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.65684184 |
114 | protein K48-linked deubiquitination (GO:0071108) | 2.65237665 |
115 | NADH metabolic process (GO:0006734) | 2.64222599 |
116 | endocardial cushion development (GO:0003197) | 2.62905251 |
117 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.62316308 |
118 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.61844669 |
119 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.61623375 |
120 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.59922584 |
121 | collagen metabolic process (GO:0032963) | 2.59320265 |
122 | venous blood vessel morphogenesis (GO:0048845) | 2.58566702 |
123 | regulation of hippo signaling (GO:0035330) | 2.57969080 |
124 | regulation of gonadotropin secretion (GO:0032276) | 2.56516512 |
125 | protein localization to cell surface (GO:0034394) | 2.56245331 |
126 | multicellular organismal metabolic process (GO:0044236) | 2.56209317 |
127 | response to BMP (GO:0071772) | 2.55728482 |
128 | cellular response to BMP stimulus (GO:0071773) | 2.55728482 |
129 | negative regulation of response to extracellular stimulus (GO:0032105) | 2.55428764 |
130 | negative regulation of response to nutrient levels (GO:0032108) | 2.55428764 |
131 | glomerular basement membrane development (GO:0032836) | 2.54959396 |
132 | branched-chain amino acid catabolic process (GO:0009083) | 2.54582996 |
133 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.54557905 |
134 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.54172405 |
135 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.53935091 |
136 | surfactant homeostasis (GO:0043129) | 2.52310925 |
137 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.51367301 |
138 | regulation of cardioblast proliferation (GO:0003264) | 2.51238936 |
139 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.51238936 |
140 | regulation of receptor binding (GO:1900120) | 2.49584827 |
141 | regulation of p38MAPK cascade (GO:1900744) | 2.49482496 |
142 | collagen catabolic process (GO:0030574) | 2.49454344 |
143 | triglyceride metabolic process (GO:0006641) | 2.49063346 |
144 | negative regulation of protein localization to cell surface (GO:2000009) | 2.49034109 |
145 | behavioral response to pain (GO:0048266) | 2.48358861 |
146 | positive regulation of p38MAPK cascade (GO:1900745) | 2.48104910 |
147 | adherens junction assembly (GO:0034333) | 2.48066490 |
148 | hemidesmosome assembly (GO:0031581) | 2.47803203 |
149 | negative regulation of blood pressure (GO:0045776) | 2.47545446 |
150 | protein polyglutamylation (GO:0018095) | 2.47481918 |
151 | metanephric epithelium development (GO:0072207) | 2.46813917 |
152 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.46189445 |
153 | positive regulation of lipid catabolic process (GO:0050996) | 2.46180644 |
154 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.46122297 |
155 | negative regulation of protein autophosphorylation (GO:0031953) | 2.45984466 |
156 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.44372921 |
157 | iron ion import (GO:0097286) | 2.43439611 |
158 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.43343734 |
159 | negative regulation of platelet activation (GO:0010544) | 2.43231626 |
160 | wound healing, spreading of epidermal cells (GO:0035313) | 2.42972460 |
161 | negative regulation of cell size (GO:0045792) | 2.42764272 |
162 | virion attachment to host cell (GO:0019062) | 2.42449459 |
163 | adhesion of symbiont to host cell (GO:0044650) | 2.42449459 |
164 | endocytic recycling (GO:0032456) | 2.42418667 |
165 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.42157477 |
166 | regulation of female receptivity (GO:0045924) | 2.40368829 |
167 | thyroid gland development (GO:0030878) | 2.39898453 |
168 | tricarboxylic acid cycle (GO:0006099) | 2.39657629 |
169 | regulation of DNA biosynthetic process (GO:2000278) | 2.38283635 |
170 | dermatan sulfate metabolic process (GO:0030205) | 2.37924006 |
171 | mesonephros development (GO:0001823) | 2.37345838 |
172 | regulation of metanephros development (GO:0072215) | 2.34905928 |
173 | negative regulation of lipid storage (GO:0010888) | 2.34673133 |
174 | regulation of appetite (GO:0032098) | 2.33978931 |
175 | regulation of response to food (GO:0032095) | 2.33563921 |
176 | ovulation cycle (GO:0042698) | 2.33411358 |
177 | transmission of nerve impulse (GO:0019226) | 2.31583736 |
178 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.29355963 |
179 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.29355963 |
180 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.28701344 |
181 | negative regulation of hormone metabolic process (GO:0032351) | 2.27390988 |
182 | positive regulation of action potential (GO:0045760) | 2.27316564 |
183 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.26643200 |
184 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.23798619 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.74889958 |
2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.64520179 |
3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.34511888 |
4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.09009675 |
5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.86032589 |
6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.83731702 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.58634900 |
8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.10037893 |
9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.65325551 |
10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.58303219 |
11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48165902 |
12 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.41059446 |
13 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.37062895 |
14 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.35779682 |
15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.34985116 |
16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.26933346 |
17 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.21989871 |
18 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.18762026 |
19 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.05683894 |
20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05161574 |
21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.04460187 |
22 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.03066662 |
23 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.98622263 |
24 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.97531748 |
25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.97338053 |
26 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.96979297 |
27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95690637 |
28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.95024760 |
29 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.89001769 |
30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.88990941 |
31 | CJUN_26792858_Chip-Seq_BT549_Human | 1.83471964 |
32 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.77101213 |
33 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.76593981 |
34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.73349299 |
35 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.68965679 |
36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.68631912 |
37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65633863 |
38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.65478338 |
39 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.65412346 |
40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65363606 |
41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.64901053 |
42 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.63294335 |
43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60500865 |
44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.58412650 |
45 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.58179521 |
46 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.57648246 |
47 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.56472800 |
48 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.56472800 |
49 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.50569202 |
50 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.50219072 |
51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.49673811 |
52 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.48458648 |
53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47242383 |
54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46979759 |
55 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.46887580 |
56 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.46683866 |
57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.43966283 |
58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.43966283 |
59 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.43583409 |
60 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.42234723 |
61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40974921 |
62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.39333750 |
63 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.36891276 |
64 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36537322 |
65 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34925837 |
66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.33965671 |
67 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.33377396 |
68 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.31914512 |
69 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.30642207 |
70 | * P68_20966046_ChIP-Seq_HELA_Human | 1.29338702 |
71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29318887 |
72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.28059734 |
73 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28010510 |
74 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.26279541 |
75 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.25681372 |
76 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24864255 |
77 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.23528916 |
78 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.23108226 |
79 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23079991 |
80 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22698340 |
81 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21902039 |
82 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.20103123 |
83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19607728 |
84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18906700 |
85 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.18504486 |
86 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.18372506 |
87 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.18372506 |
88 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18249855 |
89 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18249855 |
90 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17132315 |
91 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16426692 |
92 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.15651864 |
93 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15575425 |
94 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15334466 |
95 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.14962990 |
96 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.13664316 |
97 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12878985 |
98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12150080 |
99 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.11016614 |
100 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.09218577 |
101 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.09026266 |
102 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.08675213 |
103 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.08599184 |
104 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08582775 |
105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07234423 |
106 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06415312 |
107 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05555160 |
108 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05444505 |
109 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05394730 |
110 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05070040 |
111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05031734 |
112 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.03929289 |
113 | ERA_21632823_ChIP-Seq_H3396_Human | 1.03662672 |
114 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03652400 |
115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03393758 |
116 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00295214 |
117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00132132 |
118 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.99723556 |
119 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.99595981 |
120 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.99175147 |
121 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.98406120 |
122 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98355741 |
123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96676788 |
124 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95803553 |
125 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.95216989 |
126 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94812395 |
127 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94621641 |
128 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94567174 |
129 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.94524127 |
130 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94422189 |
131 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93972253 |
132 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.93725782 |
133 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.93704185 |
134 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93408321 |
135 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92748799 |
136 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92546090 |
137 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.92109044 |
138 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.92024773 |
139 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91998054 |
140 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91453468 |
141 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91356341 |
142 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90995476 |
143 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90626756 |
144 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.90452556 |
145 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.90441646 |
146 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90323386 |
147 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.89943205 |
148 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.89021861 |
149 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88840751 |
150 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88568493 |
151 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.87500732 |
152 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.87089324 |
153 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86587555 |
154 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85769753 |
155 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.85688743 |
156 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85344029 |
157 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.85180790 |
158 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.85010140 |
159 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.84941085 |
160 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.84676288 |
161 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82720802 |
162 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81841919 |
163 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81766997 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 6.30786172 |
2 | MP0003646_muscle_fatigue | 5.35973102 |
3 | MP0005670_abnormal_white_adipose | 4.24600413 |
4 | MP0005275_abnormal_skin_tensile | 4.08944599 |
5 | MP0003705_abnormal_hypodermis_morpholog | 3.69424700 |
6 | MP0005666_abnormal_adipose_tissue | 3.13242268 |
7 | MP0004130_abnormal_muscle_cell | 2.91730715 |
8 | MP0001958_emphysema | 2.87732656 |
9 | MP0004272_abnormal_basement_membrane | 2.77957067 |
10 | MP0002837_dystrophic_cardiac_calcinosis | 2.77732194 |
11 | MP0000013_abnormal_adipose_tissue | 2.68139981 |
12 | MP0004185_abnormal_adipocyte_glucose | 2.60494056 |
13 | MP0005375_adipose_tissue_phenotype | 2.56247102 |
14 | MP0003279_aneurysm | 2.51831740 |
15 | MP0004145_abnormal_muscle_electrophysio | 2.36641062 |
16 | MP0000751_myopathy | 2.22354673 |
17 | MP0005503_abnormal_tendon_morphology | 2.12185365 |
18 | MP0000003_abnormal_adipose_tissue | 2.09105649 |
19 | MP0003566_abnormal_cell_adhesion | 2.09029152 |
20 | MP0003011_delayed_dark_adaptation | 2.03722620 |
21 | MP0000049_abnormal_middle_ear | 2.02348566 |
22 | MP0001968_abnormal_touch/_nociception | 1.88634801 |
23 | MP0005623_abnormal_meninges_morphology | 1.75389029 |
24 | MP0003879_abnormal_hair_cell | 1.75203267 |
25 | MP0000678_abnormal_parathyroid_gland | 1.73831394 |
26 | MP0002736_abnormal_nociception_after | 1.68177210 |
27 | MP0000750_abnormal_muscle_regeneration | 1.65004683 |
28 | MP0009250_abnormal_appendicular_skeleto | 1.64134412 |
29 | MP0002971_abnormal_brown_adipose | 1.63969086 |
30 | MP0009384_cardiac_valve_regurgitation | 1.59209305 |
31 | MP0003191_abnormal_cellular_cholesterol | 1.51821496 |
32 | MP0010329_abnormal_lipoprotein_level | 1.49182684 |
33 | MP0001348_abnormal_lacrimal_gland | 1.48329816 |
34 | MP0002295_abnormal_pulmonary_circulatio | 1.48149544 |
35 | MP0005360_urolithiasis | 1.46918371 |
36 | MP0009115_abnormal_fat_cell | 1.46509666 |
37 | MP0010368_abnormal_lymphatic_system | 1.43564339 |
38 | MP0002060_abnormal_skin_morphology | 1.42996645 |
39 | MP0002876_abnormal_thyroid_physiology | 1.40853048 |
40 | MP0004084_abnormal_cardiac_muscle | 1.38084935 |
41 | MP0002139_abnormal_hepatobiliary_system | 1.37956183 |
42 | MP0004087_abnormal_muscle_fiber | 1.37794496 |
43 | MP0002933_joint_inflammation | 1.37553291 |
44 | MP0000749_muscle_degeneration | 1.37520797 |
45 | MP0009780_abnormal_chondrocyte_physiolo | 1.35648247 |
46 | MP0003091_abnormal_cell_migration | 1.34239130 |
47 | MP0006138_congestive_heart_failure | 1.34186630 |
48 | MP0006292_abnormal_olfactory_placode | 1.32104440 |
49 | MP0000537_abnormal_urethra_morphology | 1.31640324 |
50 | MP0008775_abnormal_heart_ventricle | 1.31025280 |
51 | MP0002160_abnormal_reproductive_system | 1.30739003 |
52 | MP0002108_abnormal_muscle_morphology | 1.24713752 |
53 | MP0000230_abnormal_systemic_arterial | 1.24201033 |
54 | MP0003959_abnormal_lean_body | 1.22414260 |
55 | MP0002249_abnormal_larynx_morphology | 1.20956031 |
56 | MP0005646_abnormal_pituitary_gland | 1.19961981 |
57 | MP0003942_abnormal_urinary_system | 1.19867003 |
58 | MP0005334_abnormal_fat_pad | 1.18923039 |
59 | MP0002168_other_aberrant_phenotype | 1.18682948 |
60 | MP0009053_abnormal_anal_canal | 1.18008051 |
61 | MP0006054_spinal_hemorrhage | 1.17004601 |
62 | MP0003045_fibrosis | 1.16836649 |
63 | MP0004133_heterotaxia | 1.15816437 |
64 | MP0005330_cardiomyopathy | 1.15675889 |
65 | MP0004215_abnormal_myocardial_fiber | 1.15548221 |
66 | MP0000759_abnormal_skeletal_muscle | 1.14903250 |
67 | MP0005620_abnormal_muscle_contractility | 1.14289765 |
68 | MP0000733_abnormal_muscle_development | 1.13340269 |
69 | MP0001879_abnormal_lymphatic_vessel | 1.11865671 |
70 | MP0002118_abnormal_lipid_homeostasis | 1.10788311 |
71 | MP0002970_abnormal_white_adipose | 1.10018725 |
72 | MP0002735_abnormal_chemical_nociception | 1.09384653 |
73 | MP0002733_abnormal_thermal_nociception | 1.07535655 |
74 | MP0002972_abnormal_cardiac_muscle | 1.06227399 |
75 | MP0005023_abnormal_wound_healing | 1.06090338 |
76 | MP0001853_heart_inflammation | 1.05396333 |
77 | MP0001905_abnormal_dopamine_level | 1.05121249 |
78 | MP0002896_abnormal_bone_mineralization | 1.04621620 |
79 | MP0001661_extended_life_span | 1.03309402 |
80 | MP0005332_abnormal_amino_acid | 1.02711286 |
81 | MP0003300_gastrointestinal_ulcer | 1.02274500 |
82 | MP0005385_cardiovascular_system_phenoty | 1.01789794 |
83 | MP0001544_abnormal_cardiovascular_syste | 1.01789794 |
84 | MP0001542_abnormal_bone_strength | 1.00425213 |
85 | MP0002932_abnormal_joint_morphology | 0.99777070 |
86 | MP0003137_abnormal_impulse_conducting | 0.99347782 |
87 | MP0004885_abnormal_endolymph | 0.98878620 |
88 | MP0003828_pulmonary_edema | 0.98730209 |
89 | MP0003283_abnormal_digestive_organ | 0.98531882 |
90 | MP0009643_abnormal_urine_homeostasis | 0.98270904 |
91 | MP0002272_abnormal_nervous_system | 0.97761502 |
92 | MP0001756_abnormal_urination | 0.95589520 |
93 | MP0010352_gastrointestinal_tract_polyps | 0.95306385 |
94 | MP0001970_abnormal_pain_threshold | 0.94995269 |
95 | MP0000747_muscle_weakness | 0.94636891 |
96 | MP0005164_abnormal_response_to | 0.93945961 |
97 | MP0000534_abnormal_ureter_morphology | 0.93262190 |
98 | MP0002877_abnormal_melanocyte_morpholog | 0.93146429 |
99 | MP0005508_abnormal_skeleton_morphology | 0.93016526 |
100 | MP0000538_abnormal_urinary_bladder | 0.92397957 |
101 | MP0005595_abnormal_vascular_smooth | 0.92158694 |
102 | MP0003252_abnormal_bile_duct | 0.91973196 |
103 | MP0004134_abnormal_chest_morphology | 0.91270115 |
104 | MP0002796_impaired_skin_barrier | 0.90731000 |
105 | MP0000681_abnormal_thyroid_gland | 0.89342637 |
106 | MP0010630_abnormal_cardiac_muscle | 0.85129781 |
107 | MP0005551_abnormal_eye_electrophysiolog | 0.84553180 |
108 | MP0005389_reproductive_system_phenotype | 0.84297805 |
109 | MP0004036_abnormal_muscle_relaxation | 0.83965597 |
110 | MP0001299_abnormal_eye_distance/ | 0.82633432 |
111 | MP0000343_altered_response_to | 0.81791807 |
112 | MP0010030_abnormal_orbit_morphology | 0.81549920 |
113 | MP0000767_abnormal_smooth_muscle | 0.80977931 |
114 | MP0002133_abnormal_respiratory_system | 0.80802671 |
115 | MP0005388_respiratory_system_phenotype | 0.80802671 |
116 | MP0006276_abnormal_autonomic_nervous | 0.80569262 |
117 | MP0002734_abnormal_mechanical_nocicepti | 0.80171274 |
118 | MP0004085_abnormal_heartbeat | 0.78799354 |
119 | MP0002909_abnormal_adrenal_gland | 0.78684995 |
120 | MP0001177_atelectasis | 0.78198747 |
121 | MP0008004_abnormal_stomach_pH | 0.78008721 |
122 | MP0001440_abnormal_grooming_behavior | 0.77978210 |
123 | MP0000026_abnormal_inner_ear | 0.77386288 |
124 | MP0001243_abnormal_dermal_layer | 0.77152214 |
125 | MP0002653_abnormal_ependyma_morphology | 0.76963687 |
126 | MP0003724_increased_susceptibility_to | 0.75542309 |
127 | MP0000163_abnormal_cartilage_morphology | 0.75424495 |
128 | MP0005365_abnormal_bile_salt | 0.75365915 |
129 | MP0002269_muscular_atrophy | 0.75117673 |
130 | MP0002106_abnormal_muscle_physiology | 0.74530052 |
131 | MP0003950_abnormal_plasma_membrane | 0.74002325 |
132 | MP0010386_abnormal_urinary_bladder | 0.73210977 |
133 | MP0004233_abnormal_muscle_weight | 0.73202770 |
134 | MP0002128_abnormal_blood_circulation | 0.72635298 |
135 | MP0004484_altered_response_of | 0.71390847 |
136 | MP0003186_abnormal_redox_activity | 0.70363568 |
137 | MP0008961_abnormal_basal_metabolism | 0.69986362 |
138 | MP0001727_abnormal_embryo_implantation | 0.69805554 |
139 | MP0001502_abnormal_circadian_rhythm | 0.69473607 |
140 | MP0005535_abnormal_body_temperature | 0.69152128 |
141 | MP0005369_muscle_phenotype | 0.69105333 |
142 | MP0009745_abnormal_behavioral_response | 0.69063822 |
143 | MP0005390_skeleton_phenotype | 0.68792686 |
144 | MP0005448_abnormal_energy_balance | 0.67627602 |
145 | MP0000467_abnormal_esophagus_morphology | 0.67326378 |
146 | MP0005165_increased_susceptibility_to | 0.67074427 |
147 | MP0001963_abnormal_hearing_physiology | 0.66976734 |
148 | MP0000609_abnormal_liver_physiology | 0.66255144 |
149 | MP0005257_abnormal_intraocular_pressure | 0.65558177 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cutaneous melanoma (HP:0012056) | 6.34153717 |
2 | Premature rupture of membranes (HP:0001788) | 6.12690156 |
3 | Protrusio acetabuli (HP:0003179) | 5.72696806 |
4 | Increased connective tissue (HP:0009025) | 4.14858069 |
5 | Ankle contracture (HP:0006466) | 3.88476593 |
6 | Cerebral aneurysm (HP:0004944) | 3.67831077 |
7 | Type 1 muscle fiber predominance (HP:0003803) | 3.64100827 |
8 | Aortic dissection (HP:0002647) | 3.63838888 |
9 | Broad metatarsal (HP:0001783) | 3.52424816 |
10 | Shallow orbits (HP:0000586) | 3.49233726 |
11 | Acanthosis nigricans (HP:0000956) | 3.35819244 |
12 | Muscle fiber splitting (HP:0003555) | 3.34311144 |
13 | Atrophic scars (HP:0001075) | 3.29722645 |
14 | Spinal rigidity (HP:0003306) | 3.26916858 |
15 | Meningioma (HP:0002858) | 3.23331305 |
16 | Peritonitis (HP:0002586) | 3.21930477 |
17 | Increased variability in muscle fiber diameter (HP:0003557) | 3.14226302 |
18 | Short femoral neck (HP:0100864) | 3.13304960 |
19 | Mesomelia (HP:0003027) | 3.11962481 |
20 | Right ventricular cardiomyopathy (HP:0011663) | 3.05551568 |
21 | Joint stiffness (HP:0001387) | 3.05486727 |
22 | Aortic aneurysm (HP:0004942) | 3.04890702 |
23 | Oligomenorrhea (HP:0000876) | 3.02124284 |
24 | Radial bowing (HP:0002986) | 3.00518810 |
25 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 3.00339363 |
26 | Fragile skin (HP:0001030) | 2.99018022 |
27 | Soft skin (HP:0000977) | 2.94425832 |
28 | Morphological abnormality of the middle ear (HP:0008609) | 2.90523076 |
29 | Dilatation of the ascending aorta (HP:0005111) | 2.85210413 |
30 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.83324388 |
31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.82715175 |
32 | Difficulty running (HP:0009046) | 2.76974423 |
33 | Increased corneal curvature (HP:0100692) | 2.73861094 |
34 | Keratoconus (HP:0000563) | 2.73861094 |
35 | Mitral valve prolapse (HP:0001634) | 2.70747423 |
36 | Myotonia (HP:0002486) | 2.66098112 |
37 | Cervical subluxation (HP:0003308) | 2.65311068 |
38 | Decreased subcutaneous fat (HP:0001002) | 2.64969789 |
39 | Methylmalonic aciduria (HP:0012120) | 2.64884468 |
40 | Genetic anticipation (HP:0003743) | 2.62272760 |
41 | Difficulty climbing stairs (HP:0003551) | 2.60090668 |
42 | Neonatal short-limb short stature (HP:0008921) | 2.58878597 |
43 | Ulnar deviation of the wrist (HP:0003049) | 2.58459766 |
44 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.57290865 |
45 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.53744876 |
46 | Bladder diverticulum (HP:0000015) | 2.53314740 |
47 | Hyporeflexia of lower limbs (HP:0002600) | 2.52913402 |
48 | Follicular hyperkeratosis (HP:0007502) | 2.52274694 |
49 | Mesangial abnormality (HP:0001966) | 2.52227674 |
50 | Hyperglycinuria (HP:0003108) | 2.48770848 |
51 | Methylmalonic acidemia (HP:0002912) | 2.46932567 |
52 | Hypertriglyceridemia (HP:0002155) | 2.46647516 |
53 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.46534245 |
54 | Blue sclerae (HP:0000592) | 2.46120623 |
55 | Bowing of the arm (HP:0006488) | 2.45291020 |
56 | Bowed forearm bones (HP:0003956) | 2.45291020 |
57 | Limited hip movement (HP:0008800) | 2.44770652 |
58 | Hyperthyroidism (HP:0000836) | 2.44688765 |
59 | Abnormality of proline metabolism (HP:0010907) | 2.38552480 |
60 | Hydroxyprolinuria (HP:0003080) | 2.38552480 |
61 | Scapular winging (HP:0003691) | 2.38143313 |
62 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 2.37962772 |
63 | Bradycardia (HP:0001662) | 2.37454167 |
64 | Upper limb amyotrophy (HP:0009129) | 2.35457408 |
65 | Distal upper limb amyotrophy (HP:0007149) | 2.35457408 |
66 | Diplopia (HP:0000651) | 2.34888919 |
67 | Abnormality of binocular vision (HP:0011514) | 2.34888919 |
68 | Slender build (HP:0001533) | 2.32431460 |
69 | Genu recurvatum (HP:0002816) | 2.32054761 |
70 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.32019021 |
71 | Congenital, generalized hypertrichosis (HP:0004540) | 2.30813122 |
72 | Infantile muscular hypotonia (HP:0008947) | 2.30551222 |
73 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.29300527 |
74 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.28926106 |
75 | Aneurysm (HP:0002617) | 2.27084286 |
76 | Abnormality of dentin (HP:0010299) | 2.25919287 |
77 | Short hallux (HP:0010109) | 2.24586453 |
78 | Lymphangioma (HP:0100764) | 2.21145933 |
79 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.20786509 |
80 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.20301786 |
81 | Coronal craniosynostosis (HP:0004440) | 2.19609916 |
82 | Porencephaly (HP:0002132) | 2.18366946 |
83 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.17293909 |
84 | Ovoid vertebral bodies (HP:0003300) | 2.17264862 |
85 | Wormian bones (HP:0002645) | 2.16581732 |
86 | Irregular vertebral endplates (HP:0003301) | 2.16544158 |
87 | Thin bony cortex (HP:0002753) | 2.15441195 |
88 | Hemiplegia (HP:0002301) | 2.15132349 |
89 | Visual hallucinations (HP:0002367) | 2.13523956 |
90 | Round ear (HP:0100830) | 2.11732678 |
91 | Hyperextensible skin (HP:0000974) | 2.09979384 |
92 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.09866594 |
93 | Abnormality of glycine metabolism (HP:0010895) | 2.09866594 |
94 | Lipoatrophy (HP:0100578) | 2.09699607 |
95 | Hypoplasia of the uterus (HP:0000013) | 2.08623717 |
96 | Agitation (HP:0000713) | 2.08108944 |
97 | Abnormal cartilage morphology (HP:0002763) | 2.06786613 |
98 | Congenital stationary night blindness (HP:0007642) | 2.05800119 |
99 | Venous abnormality (HP:0002624) | 2.05237193 |
100 | Aortic regurgitation (HP:0001659) | 2.04765788 |
101 | Ketoacidosis (HP:0001993) | 2.04308246 |
102 | Adactyly (HP:0009776) | 2.04207764 |
103 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.03078948 |
104 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.02250682 |
105 | Short 4th metacarpal (HP:0010044) | 2.02250682 |
106 | Ectopia lentis (HP:0001083) | 2.01183344 |
107 | Myocardial infarction (HP:0001658) | 2.01103244 |
108 | Fused cervical vertebrae (HP:0002949) | 1.99840820 |
109 | Elbow flexion contracture (HP:0002987) | 1.99666198 |
110 | Pendular nystagmus (HP:0012043) | 1.99295286 |
111 | Long toe (HP:0010511) | 1.99250864 |
112 | Osteolytic defects of the hand bones (HP:0009699) | 1.97661680 |
113 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97661680 |
114 | Camptodactyly of toe (HP:0001836) | 1.96521281 |
115 | Buphthalmos (HP:0000557) | 1.95882396 |
116 | Vertebral compression fractures (HP:0002953) | 1.95806296 |
117 | Wrist flexion contracture (HP:0001239) | 1.94687432 |
118 | Knee flexion contracture (HP:0006380) | 1.94228628 |
119 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.94079245 |
120 | Abnormality of the vertebral endplates (HP:0005106) | 1.93441226 |
121 | Type II lissencephaly (HP:0007260) | 1.91641754 |
122 | Abnormal delivery (HP:0001787) | 1.91459322 |
123 | Aplasia of the musculature (HP:0100854) | 1.89122013 |
124 | Gout (HP:0001997) | 1.88999223 |
125 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.88482183 |
126 | Overgrowth (HP:0001548) | 1.88393151 |
127 | Hyperglycinemia (HP:0002154) | 1.87378169 |
128 | Short nail (HP:0001799) | 1.87280589 |
129 | Synostosis of carpal bones (HP:0005048) | 1.86539521 |
130 | Hematochezia (HP:0002573) | 1.85094858 |
131 | Hand muscle atrophy (HP:0009130) | 1.84355087 |
132 | Biconcave vertebral bodies (HP:0004586) | 1.83382278 |
133 | Severe visual impairment (HP:0001141) | 1.82686861 |
134 | Bone cyst (HP:0012062) | 1.82565192 |
135 | Sudden death (HP:0001699) | 1.81168457 |
136 | Asymmetric septal hypertrophy (HP:0001670) | 1.80974354 |
137 | Confusion (HP:0001289) | 1.80631079 |
138 | Abnormality of the calf musculature (HP:0001430) | 1.79939976 |
139 | Abnormality of the neuromuscular junction (HP:0003398) | 1.79875254 |
140 | Fatigable weakness (HP:0003473) | 1.79875254 |
141 | Benign neoplasm of the central nervous system (HP:0100835) | 1.79798625 |
142 | Abnormality of the costochondral junction (HP:0000919) | 1.79385281 |
143 | Chondrocalcinosis (HP:0000934) | 1.78361223 |
144 | Chorioretinal atrophy (HP:0000533) | 1.78274609 |
145 | Vascular tortuosity (HP:0004948) | 1.78261018 |
146 | Xanthomatosis (HP:0000991) | 1.77941096 |
147 | Absent phalangeal crease (HP:0006109) | 1.77481839 |
148 | Hypoalphalipoproteinemia (HP:0003233) | 1.77311412 |
149 | Bowel diverticulosis (HP:0005222) | 1.76076253 |
150 | Waddling gait (HP:0002515) | 1.75832467 |
151 | Hyperuricemia (HP:0002149) | 1.75403459 |
152 | Increased purine levels (HP:0004368) | 1.75403459 |
153 | Myoglobinuria (HP:0002913) | 1.74695292 |
154 | Distal lower limb amyotrophy (HP:0008944) | 1.74649739 |
155 | Hip contracture (HP:0003273) | 1.74098545 |
156 | Short 1st metacarpal (HP:0010034) | 1.73702080 |
157 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.73702080 |
158 | Wide anterior fontanel (HP:0000260) | 1.73544845 |
159 | Abnormality of the 4th metacarpal (HP:0010012) | 1.73005608 |
160 | Abnormality of the acetabulum (HP:0003170) | 1.72820427 |
161 | Achilles tendon contracture (HP:0001771) | 1.72126405 |
162 | Venous insufficiency (HP:0005293) | 1.71734028 |
163 | Ketosis (HP:0001946) | 1.71711868 |
164 | Turricephaly (HP:0000262) | 1.70510779 |
165 | Abnormality of the Achilles tendon (HP:0005109) | 1.70222881 |
166 | Generalized amyotrophy (HP:0003700) | 1.69479792 |
167 | Generalized muscle weakness (HP:0003324) | 1.69369864 |
168 | Bronchomalacia (HP:0002780) | 1.68276569 |
169 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.67719447 |
170 | Enlarged penis (HP:0000040) | 1.66210323 |
171 | Tibial bowing (HP:0002982) | 1.65005599 |
172 | Osteopenia (HP:0000938) | 1.64298877 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 5.82975701 |
2 | TTN | 3.42131389 |
3 | MAP3K13 | 3.27461992 |
4 | MUSK | 2.96570012 |
5 | SIK1 | 2.84770004 |
6 | CAMK1D | 2.81160173 |
7 | PDGFRA | 2.74684998 |
8 | PKN2 | 2.74397656 |
9 | DDR2 | 2.55076258 |
10 | ERN1 | 2.44641912 |
11 | GRK1 | 2.43501499 |
12 | RIPK1 | 2.37047269 |
13 | ADRBK2 | 2.36790025 |
14 | EPHB2 | 2.10397133 |
15 | LMTK2 | 2.04980854 |
16 | CAMK1G | 2.00742611 |
17 | LATS2 | 1.97309710 |
18 | BCKDK | 1.83365833 |
19 | PDK3 | 1.81098107 |
20 | PDK4 | 1.81098107 |
21 | TLK1 | 1.76808501 |
22 | MYLK | 1.76450796 |
23 | FER | 1.75268496 |
24 | MST1R | 1.74482578 |
25 | PINK1 | 1.70071164 |
26 | WNK4 | 1.48150472 |
27 | LATS1 | 1.41828663 |
28 | PTK2B | 1.41399469 |
29 | MAP2K1 | 1.41227372 |
30 | TAOK3 | 1.40435568 |
31 | ADRBK1 | 1.39299210 |
32 | MOS | 1.36512027 |
33 | FLT3 | 1.35437830 |
34 | TGFBR2 | 1.31154315 |
35 | PAK2 | 1.30401205 |
36 | TIE1 | 1.30214257 |
37 | LRRK2 | 1.28876143 |
38 | ILK | 1.27653652 |
39 | PTK2 | 1.23229867 |
40 | GRK5 | 1.22024543 |
41 | FRK | 1.20921325 |
42 | MAP3K11 | 1.18430689 |
43 | PTK6 | 1.15203576 |
44 | BMX | 1.13957895 |
45 | PIK3CA | 1.11762873 |
46 | PAK4 | 1.11139029 |
47 | KDR | 1.11114198 |
48 | DMPK | 1.11037142 |
49 | PAK3 | 1.07544299 |
50 | MAP2K2 | 1.07315286 |
51 | PDK2 | 1.04522989 |
52 | MARK1 | 1.03032062 |
53 | MAPK4 | 1.00165277 |
54 | PDGFRB | 0.99396456 |
55 | MET | 0.97228258 |
56 | GRK7 | 0.96138211 |
57 | MAP3K9 | 0.95779160 |
58 | PRKD3 | 0.93823510 |
59 | IKBKB | 0.93519828 |
60 | RET | 0.93502270 |
61 | ROCK1 | 0.92471811 |
62 | TXK | 0.91074625 |
63 | PHKG2 | 0.91000656 |
64 | PHKG1 | 0.91000656 |
65 | FGFR2 | 0.90987137 |
66 | TRPM7 | 0.89054734 |
67 | PRKAA2 | 0.89021650 |
68 | NEK9 | 0.88808682 |
69 | CAMK1 | 0.88256540 |
70 | CDK6 | 0.87286845 |
71 | MAP2K6 | 0.86044457 |
72 | NTRK3 | 0.84267377 |
73 | STK38L | 0.83936269 |
74 | ABL2 | 0.82242590 |
75 | KIT | 0.80580258 |
76 | EPHA2 | 0.78908620 |
77 | NTRK1 | 0.78736669 |
78 | PRKCH | 0.77190473 |
79 | RPS6KA6 | 0.76837878 |
80 | MTOR | 0.75898059 |
81 | DAPK3 | 0.75666125 |
82 | MAPK15 | 0.73308213 |
83 | PKN1 | 0.71667075 |
84 | PRKD1 | 0.70703470 |
85 | STK38 | 0.70533752 |
86 | ARAF | 0.69011838 |
87 | FGFR4 | 0.68872157 |
88 | PRKG2 | 0.67245552 |
89 | PIK3CG | 0.66975914 |
90 | FGFR3 | 0.65879843 |
91 | EEF2K | 0.64155288 |
92 | PDPK1 | 0.64053171 |
93 | PAK6 | 0.64031022 |
94 | EPHB1 | 0.62192375 |
95 | FGFR1 | 0.60592328 |
96 | PRKD2 | 0.58467649 |
97 | ROCK2 | 0.56305746 |
98 | MAP3K3 | 0.55717994 |
99 | RPS6KC1 | 0.55507006 |
100 | RPS6KL1 | 0.55507006 |
101 | CAMK2B | 0.55415197 |
102 | CDK9 | 0.53850693 |
103 | JAK1 | 0.53571300 |
104 | MAP2K3 | 0.53066271 |
105 | LIMK1 | 0.52457993 |
106 | MAP3K7 | 0.52424036 |
107 | CAMKK1 | 0.51895484 |
108 | MAPK13 | 0.51753623 |
109 | CAMKK2 | 0.51378884 |
110 | MAPKAPK5 | 0.49806120 |
111 | CAMK2G | 0.49296781 |
112 | GSK3A | 0.49227922 |
113 | NTRK2 | 0.48938951 |
114 | KSR2 | 0.48816538 |
115 | MAP4K2 | 0.48766497 |
116 | PRKCG | 0.48489644 |
117 | INSR | 0.48089541 |
118 | TESK1 | 0.47188483 |
119 | PRKAA1 | 0.46382427 |
120 | WNK1 | 0.45660811 |
121 | PRKCE | 0.45188403 |
122 | OXSR1 | 0.45181521 |
123 | MAPK12 | 0.45129301 |
124 | ERBB2 | 0.45089305 |
125 | WNK3 | 0.45069140 |
126 | JAK3 | 0.43811751 |
127 | PRKACA | 0.43417389 |
128 | MAPK7 | 0.43416715 |
129 | MAP3K6 | 0.42552156 |
130 | GRK6 | 0.41952229 |
131 | AURKA | 0.41507819 |
132 | SRC | 0.41207312 |
133 | NEK1 | 0.39249667 |
134 | PRKCA | 0.38651395 |
135 | PRKCZ | 0.38650957 |
136 | MAPKAPK3 | 0.38615756 |
137 | MAP3K2 | 0.38231276 |
138 | CAMK2A | 0.37751394 |
139 | PIM2 | 0.36986395 |
140 | STK11 | 0.35793651 |
141 | STK3 | 0.34603417 |
142 | TAOK1 | 0.34072793 |
143 | RPS6KA2 | 0.33533420 |
144 | DAPK2 | 0.33238961 |
145 | IGF1R | 0.32619620 |
146 | CDC42BPA | 0.31764070 |
147 | INSRR | 0.31590388 |
148 | RPS6KA4 | 0.31549384 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.17626858 |
2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.05233694 |
3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.89660467 |
4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.87748733 |
5 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.71242585 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.56106063 |
7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.50476213 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44841730 |
9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.43986748 |
10 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.40353103 |
11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.35714659 |
12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.98406584 |
13 | Phototransduction_Homo sapiens_hsa04744 | 1.93719270 |
14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.92507086 |
15 | Morphine addiction_Homo sapiens_hsa05032 | 1.87610608 |
16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.81765030 |
17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.80995178 |
18 | Focal adhesion_Homo sapiens_hsa04510 | 1.80088374 |
19 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.79004832 |
20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.75348046 |
21 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.72980718 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.63714552 |
23 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.60212390 |
24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.58004295 |
25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.56891080 |
26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.49232263 |
27 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.45242840 |
28 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.45166147 |
29 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.40568447 |
30 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.39782460 |
31 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.34240728 |
32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.29980243 |
33 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.28058209 |
34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.27185941 |
35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.25170365 |
36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20355803 |
37 | Peroxisome_Homo sapiens_hsa04146 | 1.18911996 |
38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.18719975 |
39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15763920 |
40 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.14610682 |
41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13788401 |
42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.13778993 |
43 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.12142804 |
44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12132027 |
45 | Olfactory transduction_Homo sapiens_hsa04740 | 1.11954573 |
46 | Taste transduction_Homo sapiens_hsa04742 | 1.10312569 |
47 | Bladder cancer_Homo sapiens_hsa05219 | 1.08521221 |
48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.08282254 |
49 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.06922524 |
50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.05314130 |
51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.05179415 |
52 | Amoebiasis_Homo sapiens_hsa05146 | 1.03300705 |
53 | Insulin secretion_Homo sapiens_hsa04911 | 1.01914200 |
54 | Circadian entrainment_Homo sapiens_hsa04713 | 1.01404288 |
55 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.01033880 |
56 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.00062828 |
57 | Insulin resistance_Homo sapiens_hsa04931 | 0.99806731 |
58 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.99624860 |
59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96580309 |
60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95005198 |
61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94057921 |
62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.93680946 |
63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92812204 |
64 | Adherens junction_Homo sapiens_hsa04520 | 0.88580623 |
65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88092387 |
66 | Bile secretion_Homo sapiens_hsa04976 | 0.87061718 |
67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.85095019 |
68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84557116 |
69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.83559468 |
70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83152513 |
71 | Axon guidance_Homo sapiens_hsa04360 | 0.83106883 |
72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.82755249 |
73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82218382 |
74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81595133 |
75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80188246 |
76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.79385055 |
77 | ABC transporters_Homo sapiens_hsa02010 | 0.78853582 |
78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.78087660 |
79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76481981 |
80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74948819 |
81 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74615560 |
82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74117281 |
83 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73305121 |
84 | Tight junction_Homo sapiens_hsa04530 | 0.73109782 |
85 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.72842469 |
86 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72363814 |
87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71815496 |
88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70447854 |
89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70010978 |
90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.69265893 |
91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69109825 |
92 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.67813329 |
93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.66811062 |
94 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66120411 |
95 | Glioma_Homo sapiens_hsa05214 | 0.65446517 |
96 | Melanoma_Homo sapiens_hsa05218 | 0.65111744 |
97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64815945 |
98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64791068 |
99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64523287 |
100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64490880 |
101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63496769 |
102 | Salivary secretion_Homo sapiens_hsa04970 | 0.63353201 |
103 | Ribosome_Homo sapiens_hsa03010 | 0.63262519 |
104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63245374 |
105 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.59953994 |
106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59663852 |
107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59546429 |
108 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58325844 |
109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58222424 |
110 | Renin secretion_Homo sapiens_hsa04924 | 0.57348344 |
111 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57120424 |
112 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56934519 |
113 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55257862 |
114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55072066 |
115 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55012472 |
116 | Lysine degradation_Homo sapiens_hsa00310 | 0.54363203 |
117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54236269 |
118 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53967433 |
119 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52266228 |
120 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52198253 |
121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51962193 |
122 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51133811 |
123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50452557 |
124 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49910034 |
125 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48907302 |
126 | Platelet activation_Homo sapiens_hsa04611 | 0.48389109 |
127 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48375886 |
128 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47472496 |
129 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46886497 |
130 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46232568 |
131 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45334055 |
132 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45269077 |
133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44373776 |
134 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44292595 |
135 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44128105 |
136 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.43416337 |
137 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43117074 |
138 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42645631 |
139 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.42324399 |
140 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41952752 |
141 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41905922 |
142 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41439083 |
143 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40977695 |
144 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39366932 |
145 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.38942336 |
146 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38780705 |
147 | Malaria_Homo sapiens_hsa05144 | 0.37904712 |
148 | Gap junction_Homo sapiens_hsa04540 | 0.36096426 |
149 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.35907724 |
150 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35765178 |
151 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34756727 |
152 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34677485 |
153 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34221882 |
154 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.33140584 |
155 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31096233 |
156 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30898556 |